The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Mckelligon Brian since 2022.
This trader's CIK number is 1857447.
At the time of last reporting, Mckelligon Brian was the President and CEO of Akoya Biosciences, Inc.. (stock ticker symbol AKYA).
Also see all insider trading activities at Akoya Biosciences, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | AKYA | 0 | $0 | 30,000 | $104,977 | 22,500 | $6,816 |
| 2023 | AKYA | 0 | $0 | 32,500 | $174,504 | 32,500 | $9,846 |
| 2022 | AKYA | 0 | $0 | 15,000 | $175,845 | 15,000 | $4,545 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-06-11 | AKYA | Sale | 7,500 | 2.08 | 15,630 |
| 2024-06-11 | AKYA | Option Ex | 7,500 | .30 | 2,272 |
| 2024-06-06 | AKYA | Option Ex | 7,500 | .30 | 2,272 |
| 2024-06-06 | AKYA | Sale | 7,500 | 2.01 | 15,067 |
| 2024-03-20 | AKYA | Sale | 7,500 | 4.97 | 37,245 |
| 2024-03-20 | AKYA | Option Ex | 7,500 | .30 | 2,272 |
| 2024-03-13 | AKYA | Sale | 7,500 | 4.94 | 37,035 |
| 2023-12-19 | AKYA | Option Ex | 7,500 | .30 | 2,272 |
| 2023-12-19 | AKYA | Sale | 7,500 | 4.47 | 33,562 |
| 2023-12-12 | AKYA | Option Ex | 7,500 | .30 | 2,272 |
| 2023-12-12 | AKYA | Sale | 7,500 | 4.25 | 31,875 |
| 2023-11-20 | AKYA | Option Ex | 7,500 | .30 | 2,272 |
| 2023-11-20 | AKYA | Sale | 7,500 | 4.39 | 32,902 |
| 2023-06-06 | AKYA | Sale | 5,000 | 5.71 | 28,535 |
| 2023-06-06 | AKYA | Option Ex | 5,000 | .30 | 1,515 |
| 2023-03-14 | AKYA | Option Ex | 5,000 | .30 | 1,515 |
| 2023-03-14 | AKYA | Sale | 5,000 | 9.53 | 47,630 |
| 2022-12-06 | AKYA | Sale | 5,000 | 12.08 | 60,415 |
| 2022-12-06 | AKYA | Option Ex | 5,000 | .30 | 1,515 |
| 2022-09-07 | AKYA | Sale | 5,000 | 12.83 | 64,170 |
| 2022-09-07 | AKYA | Option Ex | 5,000 | .30 | 1,515 |
| 2022-06-15 | AKYA | Option Ex | 5,000 | .30 | 1,515 |
| 2022-06-15 | AKYA | Sale | 5,000 | 10.25 | 51,260 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mckelligon Brian (President and CEO of Akoya Biosciences, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.